Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Benzamide, N-1,3-benzodioxol-5-yl-4-methoxy-3-nitro- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

585566-11-6 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 585566-11-6 Structure
  • Basic information

    1. Product Name: Benzamide, N-1,3-benzodioxol-5-yl-4-methoxy-3-nitro-
    2. Synonyms:
    3. CAS NO:585566-11-6
    4. Molecular Formula: C15H12N2O6
    5. Molecular Weight: 316.27
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 585566-11-6.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Benzamide, N-1,3-benzodioxol-5-yl-4-methoxy-3-nitro-(CAS DataBase Reference)
    10. NIST Chemistry Reference: Benzamide, N-1,3-benzodioxol-5-yl-4-methoxy-3-nitro-(585566-11-6)
    11. EPA Substance Registry System: Benzamide, N-1,3-benzodioxol-5-yl-4-methoxy-3-nitro-(585566-11-6)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 585566-11-6(Hazardous Substances Data)

585566-11-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 585566-11-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,8,5,5,6 and 6 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 585566-11:
(8*5)+(7*8)+(6*5)+(5*5)+(4*6)+(3*6)+(2*1)+(1*1)=196
196 % 10 = 6
So 585566-11-6 is a valid CAS Registry Number.

585566-11-6Relevant articles and documents

3-AMIDOBENZAMIDES AND USES THEREOF FOR INCREASING CELLULAR LEVELS OF A3G

-

Paragraph 0084; 0085; 0086; 0087, (2016/03/13)

Disclosed are novel benzamide compounds and the uses thereof for treating diseases and disorders in a patient in need thereof by increasing cellular levels of A3G and/or other members of the A3 family of proteins in the patient. The disclosed compounds in

SUBSTITUTED N-ARYL BENZAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES

-

Page/Page column 67, (2008/06/13)

Substituted diaryl compounds of the Formulae (I, II, III), where the variables are as defined in the claims, and their pharmaceutically acceptable derivatives, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, including A? amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment are provided.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 585566-11-6